Compass Pathways PLC (NAS:CMPS)
$ 4.595 0.035 (0.77%) Market Cap: 314.39 Mil Enterprise Value: 139.99 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 38/100

Compass Pathways PLC at Citi Biopharma Co-Panel Day (Virtual) Transcript

May 18, 2022 / 03:00PM GMT
Release Date Price: $8.26 (-7.92%)
Neena Marie Bitritto;Garg
Citigroup Inc., Research Division - VP & Analyst

Hi, everybody. Thank you for joining Citi's biopharma virtual companies panel day. If you don't know me, my name is Neena Bitritto-Garg. I'm one of the biotech analysts here at Citi. And for our next panel, we'll be discussing mood disorders and mental health, and I'm really pleased to be joined by executives from 4 companies working in the space, including atai Life Sciences, Bionomics, COMPASS Pathways and Praxis Precision Medicines. (Operator Instructions)

So now I just wanted to turn it over to our panelists. Maybe if we go alphabetically by company name. So maybe Srini, if you want to start, introduce yourself and give some opening remarks on atai, and then we can go around alphabetically by company name.

Srinivas G. Rao
Atai Life Sciences N.V. - Co-Founder & Chief Scientific Officer

All right, that sounds good. Thank you so much, Neena, for the invite. And also thanks for this opportunity. Yes, briefly, my name is Srini Rao, I'm the Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot